Clinical Trials Browser

Urinary Bladder Neoplasms

Anus Neoplasms, Rectal Neoplasms, HIV Infections

Urinary Bladder Neoplasms

Non-Muscle Invasive Bladder Neoplasms

Non-Muscle Invasive Bladder Neoplasms

Appendiceal Neoplasms, Gastrointestinal Neoplasms, Necrosis, Ovarian Neoplasms, Peritoneal Neoplasms

Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Mediastinal Neoplasms, Pleural Neoplasms, Sarcoma

Urinary Bladder Neoplasms

Anal Canal Carcinoma, Anus Neoplasms

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

Non-Muscle Invasive Bladder Neoplasms

Pseudomyxoma Peritonei

Appendiceal Neoplasms, Colorectal Neoplasms

Anus Neoplasms

Urinary Bladder Neoplasms

Carcinoma, Transitional Cell

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

Appendiceal Neoplasms, Peritoneal Neoplasms, Pseudomyxoma Peritonei, Colorectal Neoplasms

Anus Neoplasms

Appendiceal Neoplasms, Colorectal Neoplasms

Colorectal Neoplasms

Squamous Cell Carcinoma of Head and Neck

Urinary Bladder Neoplasms

Carcinoma, Hepatocellular, Liver Neoplasms

Peritoneal Neoplasms, Stomach Neoplasms

Non-Muscle Invasive Bladder Neoplasms, Recurrence

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma, Transitional Cell

Locally Advanced Anal Canal Cancer

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

Urinary Bladder Neoplasms

Anus Neoplasms

Nasopharyngeal Carcinoma, Epstein-Barr Virus Infections

Anus Neoplasms

Non-Muscle Invasive Bladder Neoplasms

Lung Metastases

Clinical Trials

Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer

Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

SunRISe-5

MoonRISe-3

Individualized Response Assessment to Heated Intraperitoneal Chemotherapy (HIPEC) for the Treatment of Peritoneal Carcinomatosis From Ovarian, Colorectal, Appendiceal, or Peritoneal Mesothelioma Histologies

Phase II Trial of Lung Chemoemobolization

NICSA

Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study

A Study of Erdafitinib Versus Investigator Choice of Intravesical Chemotherapy in Participants Who Received Bacillus Calmette-Guérin (BCG) and Recurred With High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)

A Study of Intravesical SHR-1501 Combination With BCG Versus Investigator-selected Chemotherapy in Subjects With BCG-unresponsive NMIBC

HIPEC-PMP

ICARuS

Adaptive Radiation in Anal Cancer

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer

UTOPIA

Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC

REDEL

Pressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of Unresectable Appendix or Colorectal Cancer With Peritoneal Metastases, The IMPACT Trial

FOXHIPECT4

Mitomycin C in Patients With Incurable p16 Positive Oropharyngeal and p16 Negative Head and Neck Squamous Cell Carcinoma (HNSCC) Resistant to Standard Therapies

A Study of Chemotherapy and Radiation Therapy Compared to Chemotherapy and Radiation Therapy Plus MEDI4736 (Durvalumab) Immunotherapy for Bladder Cancer Which Has Spread to the Lymph Nodes, INSPIRE Trial

A Phase II Study of Intra-arterial Chemotherapy With Cisplatin and Mitomycin-C in Patients With Hepatocellular Carcinoma

Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer

COBRA-NMIBC

OHAI-NMIBC-01

CANAL-IMRT-01

In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial

IMGeS

KANALRAD

A Phase III Trial in NPC With Post-radiation Detectable Plasma EBV DNA

CORINTH

TIM

Chemoembolization for Lung Tumors